Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Mol Cancer Ther. 2020 Nov 11;20(1):11–25. doi: 10.1158/1535-7163.MCT-20-0563

Figure 6. 2D ligand-ERα interaction maps highlighting key interactions between the ligands and ERα’s amino acids during the simulations.

Figure 6.

These maps were generated from the recorded trajectories and the occurrences of the key contributing interactions between E2 (A), TTC-352 (B), BPTPE (C), and the amino acids in the binding site of ERα, as shown.